Smokeless tobacco (ST), which includes both chewing tobacco and snuff, has as many health
risks associated with its use as cigarettes. While there are many treatment programs that
focus on stopping tobacco use, there are no interventions that specifically focus on reducing
tobacco use. This study will evaluate the effectiveness of nicotine lozenge at reducing
tobacco use in ST users.
Phase:
Phase 2
Details
Lead Sponsor:
National Institute on Drug Abuse (NIDA)
Collaborators:
University of Minnesota University of Minnesota - Clinical and Translational Science Institute